Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor revision to the page content.
    Difference
    0.0%
    Check dated 2026-06-05T08:28:50.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.5.3 to v3.5.4. This represents a new release of the page's content/code, without modifying displayed study details.
    Difference
    0.0%
    Check dated 2026-05-15T04:47:22.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's revision history. The change does not modify visible content or user-facing features.
    Difference
    0.0%
    Check dated 2026-04-30T18:37:54.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated: v3.5.2 was added and v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:44:39.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0, indicating a minor metadata update with no changes to study details or results.
    Difference
    0.0%
    Check dated 2026-03-18T18:12:04.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:28:12.000Z thumbnail image

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.